LEXARIA BIOSCIENCE CORP. Stockholders' Equity Attributable to Noncontrolling Interest
LEXARIA BIOSCIENCE CORP. (LEXX) had Stockholders' Equity Attributable to Noncontrolling Interest of -$393.97 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-07-13
- 2026-05-31: Stockholders' Equity Attributable to Noncontrolling Interest -$393.97K.
- 2026-02-28: Stockholders' Equity Attributable to Noncontrolling Interest -$392.19K.
- 2025-11-30: Stockholders' Equity Attributable to Noncontrolling Interest -$389.44K.
- 2025-08-31: Stockholders' Equity Attributable to Noncontrolling Interest -$386.94K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-05-31 | -$393.97K 10-Q · filed 2026-07-13 |
| 2026-02-28 | -$392.19K 10-Q · filed 2026-04-13 |
| 2025-11-30 | -$389.44K 10-Q · filed 2026-01-13 |
| 2025-08-31 | -$386.94K 10-Q · filed 2026-07-13 |
| 2025-05-31 | -$385.55K 10-Q · filed 2025-07-14 |
| 2025-02-28 | -$384.04K 10-Q · filed 2025-04-14 |
| 2024-11-30 | -$380.28K 10-Q · filed 2025-01-10 |
| 2024-08-31 | -$377.35K 10-Q · filed 2025-07-14 |
| 2024-05-31 | -$375.57K 10-Q · filed 2024-07-12 |
| 2024-02-29 | -$372.95K 10-Q · filed 2024-04-09 |
| 2023-11-30 | -$369.75K 10-Q · filed 2024-01-12 |
| 2023-08-31 | -$364.04K 10-K · filed 2024-11-26 |
| 2023-05-31 | -$354.34K 10-Q · filed 2023-07-14 |
| 2023-02-28 | -$342.28K 10-Q · filed 2023-04-14 |
| 2022-11-30 | -$329.78K 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | -$316.41K 10-K · filed 2023-11-20 |
| 2022-05-31 | -$270.72K 10-Q · filed 2022-07-14 |
| 2022-02-28 | -$235.31K 10-Q · filed 2022-04-11 |
| 2021-11-30 | -$212.41K 10-Q · filed 2022-01-14 |
| 2021-08-31 | -$202.09K 10-K · filed 2022-11-28 |
| 2021-05-31 | -$77.51K 10-Q · filed 2021-07-15 |
| 2021-02-28 | -$67.96K 10-Q · filed 2021-04-14 |
| 2020-11-30 | -$57.04K 10-Q · filed 2021-01-14 |
| 2020-08-31 | -$42.94K 10-K · filed 2021-11-29 |
| 2020-05-31 | $13.80K 10-Q · filed 2020-06-29 |
| 2020-02-29 | $43.08K 10-Q · filed 2020-04-03 |
| 2019-11-30 | $90.22K 10-Q · filed 2020-01-09 |
| 2019-08-31 | $107.67K 10-K · filed 2020-10-15 |
| 2019-05-31 | $145.40K 10-Q · filed 2019-07-08 |
| 2019-02-28 | $994.87K 10-Q · filed 2019-04-15 |
| 2018-05-31 | $0.00 10-Q · filed 2018-07-13 |
| 2018-02-28 | $0.00 10-Q · filed 2018-04-12 |
| 2017-11-30 | $0.00 10-Q · filed 2018-01-12 |
| 2017-08-31 | -$238.48K 10-K · filed 2018-11-14 |
| 2017-05-31 | -$205.55K 10-Q · filed 2017-07-14 |
| 2017-02-28 | -$200.60K 10-Q · filed 2017-04-14 |
| 2016-11-30 | -$183.40K 10-Q · filed 2017-01-13 |
| 2016-08-31 | -$178.29K 10-K · filed 2017-11-27 |
| 2016-05-31 | -$165.97K 10-Q · filed 2016-07-13 |
| 2016-02-29 | -$159.80K 10-Q · filed 2016-04-13 |
| 2015-11-30 | -$145.09K 10-Q · filed 2016-01-08 |
| 2015-08-31 | -$115.81K 10-K · filed 2016-11-29 |
| 2015-05-31 | -$16.06K 10-Q · filed 2015-07-14 |
| 2015-02-28 | $27.44K 10-Q · filed 2015-04-14 |
| 2014-11-30 | $46.13K 10-Q · filed 2015-01-14 |
| 2014-08-31 | $0.00 10-K · filed 2015-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |